European randomised clinical trial on mPOX Infection (EPOXI)
Phase 1
Recruiting
- Conditions
- MonkeypoxTherapeutic area: Diseases [C] - Virus Diseases [C02]
- Registration Number
- CTIS2022-501979-10-00
- Lead Sponsor
- niversity Medical Center Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
PCR/NAAT-confirmed mPOX infection, The presence of active skin or mucosal lesion(s), Signed informed consent
Exclusion Criteria
Age <18 years, Pregnant and breastfeeding patients are not eligible for inclusion in this study, Lack of mental capacity to provide informed consent, Trial participation is considered not in the best interest of patient
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method